Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

Serum concentrations of free fatty acids are associated with 3-month mortality in acute heart failure patients.

Degoricija V, Trbušić M, Potočnjak I, Radulović B, Pregartner G, Berghold A, Scharnagl H, Stojakovic T, Tiran B, Frank S.

Clin Chem Lab Med. 2019 Jun 7. pii: /j/cclm.ahead-of-print/cclm-2019-0037/cclm-2019-0037.xml. doi: 10.1515/cclm-2019-0037. [Epub ahead of print]

PMID:
31188747
2.

The zinc-finger transcription factor MAZR regulates iNKT cell subset differentiation.

Orola MJ, Tizian C, Zhu C, Andersen L, Gülich AF, Alteneder M, Stojakovic T, Wiedermann U, Trauner M, Ellmeier W, Sakaguchi S.

Cell Mol Life Sci. 2019 May 7. doi: 10.1007/s00018-019-03119-z. [Epub ahead of print]

PMID:
31065747
3.

Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption.

Tardelli M, Bruschi FV, Claudel T, Fuchs CD, Auer N, Kunczer V, Stojakovic T, Scharnagl H, Habib A, Grabner GF, Zimmermann R, Lotersztajn S, Trauner M.

J Lipid Res. 2019 Jul;60(7):1284-1292. doi: 10.1194/jlr.M093369. Epub 2019 May 2.

PMID:
31048404
4.

High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial.

Drexler C, Macher S, Lindenau I, Holter M, Moritz M, Stojakovic T, Pieber TR, Schlenke P, Amrein K.

Clin Nutr. 2019 Mar 26. pii: S0261-5614(19)30139-6. doi: 10.1016/j.clnu.2019.03.025. [Epub ahead of print]

5.

Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study.

Hollstein T, Vogt A, Grenkowitz T, Stojakovic T, März W, Laufs U, Bölükbasi B, Steinhagen-Thiessen E, Scharnagl H, Kassner U.

Vascul Pharmacol. 2019 May;116:8-15. doi: 10.1016/j.vph.2019.03.002. Epub 2019 Mar 23.

PMID:
30910670
6.

LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study.

Silbernagel G, Scharnagl H, Kleber ME, Delgado G, Stojakovic T, Laaksonen R, Erdmann J, Rankinen T, Bouchard C, Landmesser U, Schunkert H, März W, Grammer TB.

Atherosclerosis. 2019 Mar;282:37-44. doi: 10.1016/j.atherosclerosis.2018.12.024. Epub 2018 Dec 28.

PMID:
30685440
7.

Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.

Sommerer C, Zeier M, Morath C, Reiser J, Scharnagl H, Stojakovic T, Delgado GE, März W, Kleber ME.

Sci Rep. 2019 Jan 24;9(1):475. doi: 10.1038/s41598-018-36960-6.

8.

Hepatocyte-specific lysosomal acid lipase deficiency protects mice from diet-induced obesity but promotes hepatic inflammation.

Leopold C, Duta-Mare M, Sachdev V, Goeritzer M, Maresch LK, Kolb D, Reicher H, Wagner B, Stojakovic T, Ruelicke T, Haemmerle G, Hoefler G, Sattler W, Kratky D.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Apr;1864(4):500-511. doi: 10.1016/j.bbalip.2019.01.007. Epub 2019 Jan 9.

9.

HDL subclasses and mortality in acute heart failure patients.

Degoricija V, Potočnjak I, Gastrager M, Pregartner G, Berghold A, Scharnagl H, Stojakovic T, Tiran B, Marsche G, Frank S.

Clin Chim Acta. 2019 Mar;490:81-87. doi: 10.1016/j.cca.2018.12.020. Epub 2018 Dec 19.

10.

High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.

Golob-Schwarzl N, Bettermann K, Mehta AK, Kessler SM, Unterluggauer J, Krassnig S, Kojima K, Chen X, Hoshida Y, Bardeesy NM, Müller H, Svendova V, Schimek MG, Diwoky C, Lipfert A, Mahajan V, Stumptner C, Thüringer A, Fröhlich LF, Stojakovic T, Nilsson KPR, Kolbe T, Rülicke T, Magin TM, Strnad P, Kiemer AK, Moriggl R, Haybaeck J.

Transl Oncol. 2019 Feb;12(2):256-268. doi: 10.1016/j.tranon.2018.10.010. Epub 2018 Nov 12.

11.

The interrelations between PCSK9 metabolism and cholesterol synthesis and absorption.

Silbernagel G, Steiner LK, Hollstein T, Fauler G, Scharnagl H, Stojakovic T, Schumann F, Bölükbasi B, März W, Steinhagen-Thiessen E, Laufs U, Kassner U.

J Lipid Res. 2019 Jan;60(1):161-167. doi: 10.1194/jlr.P088583. Epub 2018 Oct 15.

PMID:
30323110
12.

Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.

Lembeck AL, Posch F, Klocker EV, Szkandera J, Schlick K, Stojakovic T, Kornprat P, Lackner C, Gerger A, Stoeger H, Stotz M, Pichler M.

Clin Chem Lab Med. 2019 Apr 24;57(5):740-744. doi: 10.1515/cclm-2018-0016.

PMID:
30307891
13.

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer : A retrospective analysis.

Asamer E, Szkandera J, Gibiser P, Lembeck AL, Stojakovic T, Kornprat P, Lackner C, Winder T, Schlick K, Stöger H, Gerger A, Pichler M, Stotz M.

Wien Klin Wochenschr. 2018 Oct;130(19-20):569-574. doi: 10.1007/s00508-018-1383-3. Epub 2018 Aug 21.

14.

Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.

Tripolt NJ, Aberer F, Riedl R, Url J, Dimsity G, Meinitzer A, Stojakovic T, Aziz F, Hödl R, Brachtl G, Strunk D, Brodmann M, Hafner F, Sourij H.

Cardiovasc Diabetol. 2018 May 17;17(1):71. doi: 10.1186/s12933-018-0716-x.

15.

A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia.

Blom WAM, Koppenol WP, Hiemstra H, Stojakovic T, Scharnagl H, Trautwein EA.

Eur J Nutr. 2019 Jun;58(4):1615-1624. doi: 10.1007/s00394-018-1706-1. Epub 2018 May 3.

16.

Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.

Pollheimer MJ, Racedo S, Mikels-Vigdal A, Marshall D, Bowlus C, Lackner C, Madl T, Karlsen TH, Hov JR, Lyman SK, Adamkewicz J, Smith V, Moreau E, Zollner G, Eide TJ, Stojakovic T, Scharnagl H, Gruber HJ, Stauber RE, Trauner M, Fickert P.

J Hepatol. 2018 Aug;69(2):368-377. doi: 10.1016/j.jhep.2018.04.009. Epub 2018 Apr 28.

PMID:
29709678
17.

Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction.

Gergei I, Krämer BK, Scharnagl H, Stojakovic T, März W.

Peptides. 2019 Jan;111:112-117. doi: 10.1016/j.peptides.2018.04.003. Epub 2018 Apr 21.

PMID:
29684593
18.

Vitamin D supplementation and lipoprotein metabolism: A randomized controlled trial.

Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, Aberer F, Lerchbaum E, Obermayer-Pietsch B, Pieber TR, März W, Tomaschitz A, Pilz S.

J Clin Lipidol. 2018 May - Jun;12(3):588-596.e4. doi: 10.1016/j.jacl.2018.03.079. Epub 2018 Mar 15.

PMID:
29653812
19.

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2-/- mice by modulating composition, signalling and excretion of faecal bile acids.

Fuchs CD, Paumgartner G, Mlitz V, Kunczer V, Halilbasic E, Leditznig N, Wahlström A, Ståhlman M, Thüringer A, Kashofer K, Stojakovic T, Marschall HU, Trauner M.

Gut. 2018 Sep;67(9):1683-1691. doi: 10.1136/gutjnl-2017-314553. Epub 2018 Apr 10.

20.

Elevated Cardiac Troponin T in Patients With Skeletal Myopathies.

Schmid J, Liesinger L, Birner-Gruenberger R, Stojakovic T, Scharnagl H, Dieplinger B, Asslaber M, Radl R, Beer M, Polacin M, Mair J, Szolar D, Berghold A, Quasthoff S, Binder JS, Rainer PP.

J Am Coll Cardiol. 2018 Apr 10;71(14):1540-1549. doi: 10.1016/j.jacc.2018.01.070.

Supplemental Content

Loading ...
Support Center